USPTO serial 79254961
BORMIOLI PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 8, 2020
- Examiner
- CAHILL, CLARE GALLAGHER
- Law office
- TMEG LAW OFFICE 104
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BORMIOLI PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Zachary A. Aria
Zachary A. Aria Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Flasks for parenteral nutrition, namely, container and drug reconstitution system for injections and infusions, all being medical apparatus in the nature of infusion and injection devices for administering drugs; bottles for medical purposes all being for administering drugs sold empty, namely, bottles for injections, bottles for oral medicines, bottles for reagents, bottles for infusions, bottles for ophthalmic, otic or nasal applications, and oral tablet containers for dispensing medicine; dropper bottles for medical purposes for administering medication, sold empty; vaporizers for medical purposes; suction bottles for medical use, namely, feeding bottles, nursing bottles, dropper bottles for administering medication, sold empty; syringes for medical purposes; syringes for injections; haemoperfusion cartridges, namely, being structural part of dialysis machines and blood containers for medical purposes; droppers for medical purposes for administering medicine, sold empty; droppers for administering medication, sold empty; medical trays for holding surgical instruments; dosing syringes, dosing devices in the nature of pill splitters for dispensing unit doses of medicine for medical purposes; measuring spoons for administering medicine; non-spill medicine administering spoons for infants; intravenous feeding bottles; bottle stoppers, namely, bottle stoppers specifically adapted for feeding bottles and baby bottles; breast milk storage bottles; medical tubing for administering drugs; injection devices for pharmaceuticals; dropping pipettes for medical purposes; containers made of glass or plastic for pharmaceutical use or health and beauty or medical use, namely, dropper bottles sold empty for administering intravenous medications; flasks for disposal of injections, medicinal products, reagents, infusions, aerosols, vials, ampoules, cartridges, syringes, pills; bottles for aerosols being aerosol dispenser for medical use; vials being medical specimen collection devices for the collection of blood, urine, fecal matter, and to administer medication; ampoules being small sealed vial medical specimen collection devices for the collection of blood, urine, fecal matter and to administer medication; cartridges being replacement parts of drug delivery systems; syringe, pills containers being pill splitters for dispensing unit doses of medicine; diagnostic devices, namely, sample preparation device or medical diagnostic uses, blood pressure and diabetic diagnostic medical devices, diagnostic kit consisting primarily of probes, buffers and reagents for use in microbial testing used in laboratories for Point of Care Testing (POCT) for integrated electronic systems for the administration of medical substances; plastic cartridges for diagnostic use, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; consumable cartridges for diagnostic use in laboratories, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being drug delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; valves and accessories for the intravenous administration of medicinal products, namely, subcutaneous valves comprised of artificial material for implantation, feeding bottle valves, intravenous bags sold empty for intravenous therapy, intravenous feeding tubes, replacement and structural parts of injection devices for administering drugs in the nature of stoppers, connectors and IV extensions and IV cannulas, stopcock; medical diagnostic devices for sale in kits, namely, diagnostic kits consisting primarily of probes, buffers, and reagents for use in microbial testing; clinical-medical test kits containing test pieces, analysis plates and indicator papers to assess the results of analyses¸ the foregoing all being medical test kits for diabetes monitoring for home use, medical diagnostic apparatus for detecting cancer and monitoring diabetes, and blood testing apparatus; integrated electronic systems for the administration of medical substances comprised primarily of medical apparatus for intravenous administration of fluids in the nature of fluid warmers, infusion and injection devices for administering medicine, intravenous feeding tubes, and infusion and injection devices for administering drugs; integrated electronic systems for the registration of medical data comprised primarily of portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device, respiration monitors, medical devices used for the acquisition of physiological data, and medical instruments for measuring and displaying medical data being blood pressures and lung capacity; integrated electronic systems for the registration of pharmaceutical data comprised primarily of drug delivery systems, medical instruments for measuring and displaying medical data being blood pressures and lung capacity, and injection devices for pharmaceuticals; prostheses and medical implants composed of artificial materials for surgical use; sterile containers for medical products, namely, containers for medical waste, blood containers for medical purposes; sterile surgical containers, namely, containers for medical waste, blood containers for medical purposes; plastic cartridges for containing and administering medical products being specially adapted for drug delivery systems; glass cartridges for containing and administering medical products, namely, being specially adapted for drug delivery systems | ACTIVE | — |
| 020 | Plastic caps for containers; containers of plastic for pharmaceuticals for commercial use; containers, not of metal, for transporting and holding pharmaceuticals for commercial or industrial use; bottle closures, not of metal namely screw cap, tamper evident cap, child resistant cap and specialty closures; caps for containers, not of metal or paper; containers of plastic for medication for commercial use; corks for bottles, plastic tops for bottles in the nature of nonmetal screw tops, plastic caps, security tops being sealing caps and plastic caps; screw tops not of metal and plastic capsules being caps for the closing of containers being bottles; sealing caps, not of metal; locking plastic caps that cover bung openings in plastic and metal containers for tamper evident containers | ACTIVE | — |
| 021 | Cruets; cruet stands; containers for household use, namely, glass bulbs being receptacles; flasks; plastic flasks; empty spray bottles; glass cartridges for medication, empty; pill boxes for personal use; pill boxes for personal use and not for medical purposes; personal dispensers for pills or capsules for domestic use; droppers sold empty for cosmetic purposes; glass bottles sold empty; glass flasks being containers; plastic bottles, sold empty; drip preventers for bottles, namely, drop collars to stops drips; glass stoppers for bottles; bottles for pharmaceuticals sold empty; apothecary jars of glass; dispensers for liquids for use with bottles, namely, bottles pourers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bormioli Pharma S.p.a.
- Other trademarks owned by Bormioli Pharma S.p.a.
- Other trademarks owned by Bormioli Pharma S.p.a.
- Other trademarks in Class 010
- Other trademarks in Class 020
- Other trademarks in Class 021
- Similar marks named BORMIOLI PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 13, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 13, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 8, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 25, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 5, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 17, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 17, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 27, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 4, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 4, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 4, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 10, 2020 | ALIE | ASSIGNED TO LIE | — |
| Dec 18, 2019 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Dec 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2019 | PETG | PETITION TO REVIVE-GRANTED | — |
| Dec 18, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 18, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 7, 2019 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 7, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 26, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 4, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 4, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 28, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 21, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |